223 related articles for article (PubMed ID: 25311499)
1. Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.
Cummings J; Mintzer J; Brodaty H; Sano M; Banerjee S; Devanand DP; Gauthier S; Howard R; Lanctôt K; Lyketsos CG; Peskind E; Porsteinsson AP; Reich E; Sampaio C; Steffens D; Wortmann M; Zhong K;
Int Psychogeriatr; 2015 Jan; 27(1):7-17. PubMed ID: 25311499
[TBL] [Abstract][Full Text] [Related]
2. Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definition.
Sano M; Cummings J; Auer S; Bergh S; Fischer CE; Gerritsen D; Grossberg G; Ismail Z; Lanctôt K; Lapid MI; Mintzer J; Palm R; Rosenberg PB; Splaine M; Zhong K; Zhu CW
Int Psychogeriatr; 2024 Apr; 36(4):238-250. PubMed ID: 36880250
[TBL] [Abstract][Full Text] [Related]
3. Agitation in Cognitive Disorders: Use of the National Alzheimer's Coordinating Center Uniform Data Set (NACC-UDS) to Evaluate International Psychogeriatric Association Definition.
Sano M; Zhu CW; Neugroschl J; Grossman HT; Schimming C; Aloysi A
Am J Geriatr Psychiatry; 2022 Nov; 30(11):1198-1208. PubMed ID: 35562259
[TBL] [Abstract][Full Text] [Related]
4. Towards defining restlessness in individuals with dementia.
Regier NG; Gitlin LN
Aging Ment Health; 2017 May; 21(5):543-552. PubMed ID: 26743166
[TBL] [Abstract][Full Text] [Related]
5. Reduction and prevention of agitation in persons with neurocognitive disorders: an international psychogeriatric association consensus algorithm.
Cummings J; Sano M; Auer S; Bergh S; Fischer CE; Gerritsen D; Grossberg G; Ismail Z; Lanctôt K; Lapid MI; Mintzer J; Palm R; Rosenberg PB; Splaine M; Zhong K; Zhu CW
Int Psychogeriatr; 2024 Apr; 36(4):251-262. PubMed ID: 36876335
[TBL] [Abstract][Full Text] [Related]
6. Toward international consensus on the definition of agitation in cognitive disorders.
De Leo D; Zammarrelli J
Int Psychogeriatr; 2024 Apr; 36(4):221-223. PubMed ID: 36944586
[No Abstract] [Full Text] [Related]
7. A Novel Approach to Monitoring Cognitive Adverse Events for Interventional Studies Involving Advanced Dementia Patients: Insights From the Electroconvulsive Therapy for Agitation in Dementia Study.
Park S; Forester BP; Lapid MI; Harper DG; Hermida AP; Inouye SK; McClintock SM; Nykamp L; Petrides G; Schmitt EM; Seiner SJ; Mueller M; Patrick RE
J Geriatr Psychiatry Neurol; 2024 May; 37(3):234-241. PubMed ID: 37848185
[TBL] [Abstract][Full Text] [Related]
8. Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders.
Anderson KE; van Duijn E; Craufurd D; Drazinic C; Edmondson M; Goodman N; van Kammen D; Loy C; Priller J; Goodman LV
J Huntingtons Dis; 2018; 7(3):355-366. PubMed ID: 30040737
[TBL] [Abstract][Full Text] [Related]
9. Commentary on Agitation in Cognitive Disorders: Use of the National Alzheimer's Coordinating Center Uniform Data Set (NACC-UDS) to Evaluate International Psychogeriatric Association Definition.
Fischer CE
Am J Geriatr Psychiatry; 2022 Nov; 30(11):1209-1211. PubMed ID: 35641401
[No Abstract] [Full Text] [Related]
10. Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.
Cummings JL; Lyketsos CG; Peskind ER; Porsteinsson AP; Mintzer JE; Scharre DW; De La Gandara JE; Agronin M; Davis CS; Nguyen U; Shin P; Tariot PN; Siffert J
JAMA; 2015 Sep 22-29; 314(12):1242-54. PubMed ID: 26393847
[TBL] [Abstract][Full Text] [Related]
11. Advancements in the treatment of agitation in Alzheimer's disease.
Antonsdottir IM; Smith J; Keltz M; Porsteinsson AP
Expert Opin Pharmacother; 2015; 16(11):1649-56. PubMed ID: 26159445
[TBL] [Abstract][Full Text] [Related]
12. Assessment and management of behavioral and psychological symptoms of dementia.
Kales HC; Gitlin LN; Lyketsos CG
BMJ; 2015 Mar; 350():h369. PubMed ID: 25731881
[TBL] [Abstract][Full Text] [Related]
13. Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence.
Kolanowski A; Boltz M; Galik E; Gitlin LN; Kales HC; Resnick B; Van Haitsma KS; Knehans A; Sutterlin JE; Sefcik JS; Liu W; Petrovsky DV; Massimo L; Gilmore-Bykovskyi A; MacAndrew M; Brewster G; Nalls V; Jao YL; Duffort N; Scerpella D
Nurs Outlook; 2017; 65(5):515-529. PubMed ID: 28826872
[TBL] [Abstract][Full Text] [Related]
14. An update on the advancements in the treatment of agitation in Alzheimer's disease.
Porsteinsson AP; Antonsdottir IM
Expert Opin Pharmacother; 2017 Apr; 18(6):611-620. PubMed ID: 28300462
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study.
Peters ME; Schwartz S; Han D; Rabins PV; Steinberg M; Tschanz JT; Lyketsos CG
Am J Psychiatry; 2015 May; 172(5):460-5. PubMed ID: 25585033
[TBL] [Abstract][Full Text] [Related]
16. International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder.
Schaffer A; Isometsä ET; Tondo L; H Moreno D; Turecki G; Reis C; Cassidy F; Sinyor M; Azorin JM; Kessing LV; Ha K; Goldstein T; Weizman A; Beautrais A; Chou YH; Diazgranados N; Levitt AJ; Zarate CA; Rihmer Z; Yatham LN
Bipolar Disord; 2015 Feb; 17(1):1-16. PubMed ID: 25329791
[TBL] [Abstract][Full Text] [Related]
17. Progress in Treatment Development for Neuropsychiatric Symptoms in Alzheimer's Disease: Focus on Agitation and Aggression. A Report from the EU/US/CTAD Task Force.
Soto M; Abushakra S; Cummings J; Siffert J; Robert P; Vellas B; Lyketsos CG;
J Prev Alzheimers Dis; 2015 Sep; 2(3):184-188. PubMed ID: 26413494
[TBL] [Abstract][Full Text] [Related]
18. Defining agitation in the cognitively impaired-a work in progress.
Chiu E
Int Psychogeriatr; 2015 Jan; 27(1):5-6. PubMed ID: 25311548
[No Abstract] [Full Text] [Related]
19. Progresses in treating agitation: a major clinical challenge in Alzheimer's disease.
Panza F; Solfrizzi V; Seripa D; Imbimbo BP; Santamato A; Lozupone M; Prete C; Greco A; Pilotto A; Logroscino G
Expert Opin Pharmacother; 2015; 16(17):2581-8. PubMed ID: 26389682
[TBL] [Abstract][Full Text] [Related]
20. Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease.
Cummings J; Zhong K
Clin Pharmacol Ther; 2015 Nov; 98(5):483-5. PubMed ID: 26206713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
